Christopher M. Hull
( out of 1250 reviews )

Christopher M. Hull, MD

Languages spoken: English, Spanish

Clinical Locations

Midvalley Health Center Dermatology

Dermatology
Murray
801-581-2955
Directions

U of U Health Elko Specialty Clinic

Dermatology Outreach Clinic
Elko
801-581-2955
Directions

University of Utah Hospital

Dermatology, Area E
Salt Lake City
801-581-2955
Directions

  • Christopher Hull, MD has specialized expertise in the treatment of autoimmune skin diseases and viral infections of the skin. He is board certified in dermatology. His main clinical focus is general dermatology and medical dermatology including autoimmune blistering diseases.

    Specialties

    Board Certification

    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 1250 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    January 24, 2025
    UNIVERSITY HOSPITAL

    Dr. Hull gave me thoroughly professional expert diagnosis and treatment, and at the same time was friendly and took the time to chat briefly about our mutual interests in fly fishing, reading, etc. No time wasted, but a pleasant experience for sure.

    January 22, 2025
    MIDVALLEY

    Dr Hull is awesome! He has been my Dermatologist for years and it's easy to recommend him.

    January 20, 2025
    MIDVALLEY

    He is very kind and thorough. Helps with all my needs and questions. Thank you

    January 20, 2025
    MIDVALLEY

    Dr Hull has exceeded my expectations. I have struggled for a long time and have seen multiple doctors. Dr Hull is brilliant and because of his vast knowledge and expertise, he knew immediately what I had and the appropriate tests to confirm it on my first appointment. I am beyond impressed with him and his staff

    January 18, 2025
    MIDVALLEY

    Wonderful care.

    January 17, 2025
    MIDVALLEY

    He listened and told me about what I could do for my condition and respected my decision.

    January 15, 2025
    MIDVALLEY

    Dr. Hull is great. I've been going to Dr. Hull for about 14 years since moving here from Colorado. I feel that he is a true partner in my dermatological health. He is never rushed and takes whatever time is necessary.

    January 15, 2025
    MIDVALLEY

    Always treated with the utmost respect and professionally

    January 14, 2025
    MIDVALLEY

    Thank you for your knowledgeable assessment of my health care needs!

  • Christopher Hull, MD has specialized expertise in the treatment of autoimmune skin diseases and viral infections of the skin. He is board certified in dermatology. His main clinical focus is general dermatology and medical dermatology including autoimmune blistering diseases.

    Board Certification and Academic Information

    Academic Departments Dermatology -Professor
    Academic Divisions Infectious Diseases
    Board Certification
    National Board of Medical Examiners

    Education history

    Residency Dermatology - University of Utah School of Medicine Resident
    Internship Internal Medicine - University of Utah School of Medicine Intern
    Professional Medical Medicine - University of Washington School of Medicine M.D.
    Undergraduate Universidad de Granada Baccalaureate
    Undergraduate Molecular & Cell Biology - University of Colorado - Boulder B.S.

    Selected Publications

    Journal Article

    1. Stone CJ, Broadbent E, Sahni VN, Gray L, Clarke JT, Hansen CB, Rhoads JLW, Zone JJ, Hull CM, Wu YP, Kean J, Secrest AM, Hopkins ZH (2025). Use of the Connor-Davidson Resilience Scale in a Complex Medical Dermatology Clinic: Cross-sectional study evaluating associations between resilience, Health-related Quality of Life and Mental Health. J Am Acad Dermatol. (Read full article)
    2. Sahni V, Teames C, Seifert R, Conley M, deShazo R, Powell D, Rhoads JLW, Clarke JT, Hansen CB, Zone JJ, Hull CM, Hopkins ZH (2025). The association between skin allergy testing and oral squamous cell carcinoma in oral lichen planus: a retrospective cohort study. Arch Dermatol Res, 317(1), 207. (Read full article)
    3. Tristani-Firouzi B, Herron ED, Hull CM, Herron MD (2024). Scissors and curette supply solution for cutaneous sarcoid papules and nodules. JAAD Case Rep, 55, 126-127. (Read full article)
    4. Tristani-Firouzi B, Herron ED, Hull CM, Herron MD (2024). Two Techniques to Avoid Cyst Spray During Excision. Cutis, 114(1), 11-26. (Read full article)
    5. Herron ED, Snyder AM, Hull CM, LoBello S, Herron MD (2024). Fragile hands: targeting nonmelanoma skin cancer on older hands using 595 nm pulsed dye laser. Lasers Med Sci, 39(1), 101. (Read full article)
    6. Kern JA, Amanullah AA, Sahni DR, Mathis JG, Hull CM, Powell DL, Secrest AM (2023). Granulomatous cheilitis - is there a role for allergen screening and avoidance? J Dermatolog Treat, 34(1), 2171707. (Read full article)
    7. Hopkins ZH, Jimenez A, Taliercio VL, Clarke JT, Hansen CB, Hull CM, Rhoads JLW, Zone JJ, Sahni VN, Kean J, Secrest AM (2023). Skin-Related Quality of Life During Autoimmune Bullous Disease Course. JAMA Dermatol, 159(11), 1185-1194. (Read full article)
    8. Marcacci E, Truong A, Wu C, Presson AP, Lewis BKH, Hull CM (2023). Improving access to dermatologic care: A retrospective analysis of dermatology rural outreach clinics in Utah and Wyoming compared to an urban academic center. J Am Acad Dermatol. (Read full article)
    9. Hoshina Y, Wong KH, Galli J, Bacharach R, Klein J, Lebiedz-Odrobina D, Rose JW, Trump B, Hull C, Greenlee JE, Clardy SL (2023). Neurologic involvement in seronegative primary Sjögren's syndrome with positive minor salivary gland biopsy: a single-center experience. Front Neurol, 14, 1174116. (Read full article)
    10. Grant GJ, Sahni DR, Florell AJ, Hull CM, Florell SR, Miles RR, Wada DA, Bowen AR (2023). An atypical case of eosinophilic pustular folliculitis with associated secondary follicular mucinosis treated with indomethacin. JAAD Case Rep, 34, 86-89. (Read full article)
    11. Sahni D, Hull C, Grant GJ, Florell S, Wada D, Bowen A, Florell A (2022). An atypical case of eosinophilic pustular folliculitis with associated secondary follicular mucinosis treated with indomethacin. JAAD Case Rep.
    12. Amanullah AA, Sahni DR, Sahni VN, Hull CM, Powell DL, Secrest AM (2022). Reply to: current treatment modalities in granulomatous cheilitis. Int J Dermatol. (Read full article)
    13. Freeman C, Hull C, Sontheimer R, Curtis J (2020). Squamous cell carcinoma of the dorsal hands and feet after repeated exposure to ultraviolet nail lamps. Dermatol Online J, 26(3). (Read full article)
    14. Topham C, Haynes D, Frigerio A, Hull C (2019). Linear amyopathic dermatomyositis with calcinosis cutis responsive to topical sodium thiosulfate. Pediatr Dermatol, 36(4), e102-e103. (Read full article)
    15. Varedi D, Frigerio A, Scaife C, Hull C (2019). A novel case of TIF1 gamma autoantibody positive dermatomyositis associated with a non-functional pancreatic neuroendocrine tumor. Dermatol Online J, 25(3). (Read full article)
    16. Hull CM, Levin MJ, Tyring SK, Spruance SL (2013). Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis. Antimicrob Agents Chemother, 58(3), 1273-8. (Read full article)
    17. McCaughey C, Machan M, Bennett R, Zone JJ, Hull CM (2011). Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehicle-controlled study with a 6-week open-label extension to assess efficacy and safety. J Eur Acad Dermatol Venereol, 25(9), 1061-7. (Read full article)
    18. Hull CM, Harmenberg J, Arlander E, Aoki F, Bring J, Darpo B, Levin MJ, Tyring S, Spruance SL (2011). Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial. J Am Acad Dermatol, 64(4), 696.e1-11. (Read full article)
    19. Hull CM, Brunton S (2010). The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis. Postgrad Med, 122(5), 1-6. (Read full article)
    20. Hull C, Spruance S (2007). Situational antiviral drug prophylaxis for HSV type 1 recurrences. Herpes, 14(2), 37-40. (Read full article)
    21. Zone JJ, Taylor T, Hull C, Schmidt L, Meyer L (2007). IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice. J Invest Dermatol, 127(5), 1167-74. (Read full article)
    22. Liddle M, Hull C, Liu C, Powell D (2006). Contact urticaria from curcumin. Dermatitis, 17(4), 196-7. (Read full article)
    23. Hull C, Spruance S, Tyring S, Hamed K (2006). Single-dose famciclovir for the treatment of herpes labialis. Curr Med Res Opin, 22(9), 1699-702. (Read full article)
    24. Hanson N, Hull C, Meyer L (2004). Fever and lymphadenopathy in a farmer. Arch Dermatol, 140(12), 1531-6. (Read full article)
    25. Hull C, Larson A, Leachman S (2003). Pharmacogenetic candidate genes for melanoma. Pharmacogenomics, 4(6), 753-65. (Read full article)

    Review

    1. Nguyen C, Kuceki G, Birdsall M, Sahni DR, Sahni VN, Hull CM (2024). Rosacea: Practical Guidance and Challenges for Clinical Management. [Review]. Clin Cosmet Investig Dermatol, 17, 175-190. (Read full article)
    2. Hull CM, Brunton S (2010). The Role of Topical 5% Acyclovir and 1% Hydrocortisone Cream (XereseTM) in the Treatment of Recurrent Herpes Simplex Labialis. [Review]. Postgrad Med, 122(5), 1-6.

    Book Chapter

    1. Hull C, Zone JJ (Published). Dermatitis herpetiformis and linear IgA bullous dermatosis. In Bolgnia J, Jorizzo (Eds.), Dermatology (3). Elsevier Mosby.

    Case Report

    1. Jimenez A, Topham C, Varedi D, Leiferman KM, Hull C (2021). Mucosal linear IgA disease with esophageal involvement responsive to ustekinumab. JAAD Case Rep, 15, 4-6. (Read full article)
    2. Jimenez A, Hull C, Zone J (2021). Rituximab therapy for a severe case of pretibial myxedema. JAAD Case Rep, 10, 28-30. (Read full article)
    3. Abbott J, Kowalski EH, Klein S, DeShazo R, Hull CM (2020). Iatrogenic calcinosis cutis secondary to calcium chloride successfully treated with topical sodium thiosulfate. JAAD Case Rep, 6(3), 181-183. (Read full article)
    4. Jimenez A, Hull C, Zone J (2019). Dermatitis herpetiformis resistant to dapsone due to dietary iodide ingestion. JAAD Case Rep, 5(8), 713-714. (Read full article)

    Letter

    1. Seifert RM, Hull CM, deShazo RA, Powell DL, Rhoads JLW, Zone JJ, Hopkins ZH (2025). The Impact of Allergen Avoidance in Burning Mouth Syndrome: A Case Series. [Letter to the editor]. Dermatitis. (Read full article)
    2. Herron ED, Snyder AM, Hull CM, LoBello S, Herron MD (2024). Shave Biopsy with Purposeful Electrodesiccation Benefits Small Nonmelanoma Skin Cancer. [Letter to the editor]. J Cutan Med Surg, 12034754241308235. (Read full article)
    3. Ali NS, Sahni VN, Ma BC, Sahni DR, Hull CM, Powell DL, Secrest AM (2021). Reply to: low response of granulomatous cheilitis to currently established treatments. [Letter to the editor]. J Eur Acad Dermatol Venereol, 35(12), e930-e931. (Read full article)
    4. Westerdahl S, Hull CM, Clarke JT, Hansen CB, Rhoads JLW (2020). A single-center, retrospective record review of malignancy prevalence in patients with dermatomyositis with anti-transcription intermediary factor 1γ antibodies via line immunoassay versus immunoprecipitation. [Letter to the editor]. J Am Acad Dermatol, 84(2), 559-561. (Read full article)
    5. Truong A, Laggis CW, Annis TD, Secrest AM, Fino NF, Powell DL, Gardner LJ, Gregory T, Hull CM, Lewis BKH (2019). Factors associated with follow-up adherence in patients seen at a referral-based dermatology clinic for the homeless. [Letter to the editor]. J Am Acad Dermatol, 83(2), 629-631. (Read full article)
    6. Harris K, Vanderhooft L, Burt L, Vanderhooft S, Hull C (2011). Tanning business practices in Salt Lake County, Utah. [Letter to the editor]. J Am Acad Dermatol, 66(3), 513-4. (Read full article)

  • News & Podcasts

    News

    Podcasts